News
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to ...
The Food and Drug Administration (FDA) has introduced new guidelines for COVID-19 vaccines, focusing on those at highest risk for severe complications. The updated strategy will maintain the ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...
Top officials for the Food and Drug Administration laid out new requirements ... to COVID-19 vaccines, similar to the annual flu shot. Just like with flu vaccines, until now the FDA has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results